Global Hepatosplenomegaly Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 2,472.84 Million |
 Market Size (Forecast Year) |
USD 3,021.80 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球肝脾肿大市场，按治疗（药物、化疗、放疗、肝移植等）、诊断（磁共振成像 (MRI)、X 射线、超声波、血液检查、计算机断层扫描 (CT) 扫描、活检等）、症状（疲劳、压痛、发烧、恶心和呕吐、右上腹痛、腹部肿胀、持续瘙痒、棕色尿液、黄疸、白垩色粪便、疼痛等）、剂量（注射、药片、其他）、给药途径（口服、肠外、其他）、最终用户（诊所、医院、其他）、分销渠道（医院药房、零售药房、网上药房）– 行业趋势和预测到 2030 年。
肝脾肿大市场分析和规模
糖尿病和肝癌患者数量的增加将成为推动市场增长的主要动力。影响全球肝脾肿大市场增长率的另一个重要因素是医疗保健支出的增加。酒精消费量增加和老年人口增加等其他因素将对肝脾肿大市场的增长率产生积极影响。此外，肥胖的高发性和生活方式的改变将导致全球肝脾肿大市场的扩张。高胆固醇、戈谢病、尼曼匹克病、肝炎和骨质硬化症病例的增加将增加肝脾肿大的风险，并进一步提高市场的增长率。
Data Bridge Market Research 分析，全球肝脾肿大市场在 2022 年为 24.7284 亿美元，预计到 2030 年将达到 30.218 亿美元，预计在 2023-2030 年预测期内的复合年增长率为 2.6%。由于易用性和偏好性，“药物”预计将占据市场主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
肝脾肿大市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
Treatment (Medication, Chemotherapy, Radiotherapy, Liver Transplant, Others), Diagnosis (Magnetic Resonance Imaging (MRI), X-Ray, Ultrasound, Blood Tests, Computed Tomography (CT) Scan, Biopsy, Others), Symptoms (Fatigue, Tenderness, Fever, Nausea and Vomiting, Abdominal Pain in the Upper-Right Region, Swelling of the Abdomen, Persistent Itching, Brown Urine, Jaundice, Clay-Coloured Stool, Pain, Others), Dosage (Injection, Tablets, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) |
|
Countries Covered |
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa |
|
Market Players Covered |
BIOSIDUS (Argentina), F. Hoffmann-La Roche Ltd. (Switzerland), Zydus Cadila (India), NanoGen Healthcare Pvt. Ltd. (India), AMEGA Biotech (Russia), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), AbbVie Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Pfizer Inc. (U.S.), Sanofi (France), Eiger BioPharmaceuticals (U.S.), Arrowhead Pharmaceuticals, Inc. (U.S.), Hepion Pharmaceuticals, Inc. (U.S.), Antios Therapeutics, Inc. (U.S.), PharmaEssentia Corporation (Taiwan), Gilead Sciences, Inc. (U.S.), Aurobindo Pharma (India), Mylan N.V. (U.S.), Apotex Inc. (Canada), GlaxoSmithKline plc (U.K.), Cipla Inc. (India), Sun Pharmaceutical Industries Ltd. (India), and Merck & Co., Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Hepatosplenomegaly is a disorder that causes the liver and spleen to inflate and enlarge. It is the most prevalent and early symptom of Gaucher disease. More than 90% of patients have an enlarged spleen, which is generally the first sign of the disease. Spleen size can be up to 15 times greater than usual in some circumstances. Abdominal distension and discomfort are common symptoms of this growth. In 60 percent to 80 percent of Gaucher’s disease patients, the liver is enlarged. Gaucher cells aggregate in the liver and spleen, leading in an abnormal increase in their size, causing hepatosplenomegaly. Gaucher cells have a lot of glucocerebroside, a complicated lipid molecule that builds up inside cells because the beta-glucocerebrosidase enzyme in Gaucher’s disease patients doesn't work properly.
Global Hepatosplenomegaly Market Dynamics
Drivers
- Growing Prevalence of Neuropathic Pain Disorders
The rising incidence of neuropathic pain disorders globally is a significant driver for the global hepatosplenomegaly market. Neuropathic pain, often associated with conditions like diabetic neuropathy, post-herpetic neuralgia, and trigeminal neuralgia, necessitates effective pain management. Hepatosplenomegaly has proven efficacy in managing neuropathic pain, driving its demand and adoption.
- Expanding Applications and Off-Label Usage
Hepatosplenomegaly's versatility in treating various medical conditions beyond its initial intended use, such as anxiety disorders, migraines, and restless legs syndrome, contributes to market growth. Physicians and healthcare practitioners increasingly prescribe Hepatosplenomegaly off-label for these conditions, broadening its market reach and fueling demand.
Opportunity
- Rising Awareness and Education Initiatives
There is a substantial opportunity for market growth through increased awareness and educational initiatives regarding Hepatosplenomegaly's benefits, optimal usage, and potential side effects. Educating healthcare professionals, patients, and caregivers about the appropriate use of Hepatosplenomegaly, its efficacy in managing various conditions, and safety precautions can enhance its acceptance and adoption. This educational approach can not only expand the market but also foster responsible usage, which is crucial in ensuring positive outcomes and mitigating potential risks.
Restraint/Challenge
- Concerns Regarding Abuse and Dependency
One significant restraint for the global hepatosplenomegaly market is the rising concern regarding its potential for abuse and dependency. Reports of misuse and addiction, particularly when combined with other substances like opioids, have raised regulatory scrutiny and led to tighter control and monitoring of Hepatosplenomegaly prescriptions. This has the potential to limit its usage and impact the overall market growth.
This global hepatosplenomegaly market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global hepatosplenomegaly market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Recent Development
- In September 2023, Pfizer Inc. and BioNTech SE have announced that they received approval from the U.S. Food and Drug Administration (FDA) for their supplemental Biologics License Application (COMIRNATY 2023-2024 Formulation). This approval covers individuals aged 12 and above, and it includes emergency use authorization for children aged 6 months to 11 years, specifically for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine. The current vaccine season's recommendation is for a single dose for most individuals aged 5 and older. However, children under 5 years old may qualify for additional doses of this season's vaccine if they have not already completed a three-dose series with earlier formulations of a COVID-19 vaccine
Global Hepatosplenomegaly Market Scope
The global hepatosplenomegaly market is segmented on the basis of product type, application, route of administration, mode of purchase and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Capsule
- Tablet
Application
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome
Route of Administration
- Oral
- Parenteral
- Intravenous
Mode of Purchase
- Prescription
- Retail
- Over the counter
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Global Hepatosplenomegaly Market Regional Analysis/Insights
The global hepatosplenomegaly market is analysed and market size insights and trends are provided by country, product type, application, route of administration, mode of purchase and distribution channel as referenced above.
全球肝脾肿大市场报告涵盖的国家包括美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区。
北美在全球肝脾肿大市场中占据主导地位并拥有最高的增长率，这得益于治疗产品批准数量的激增以及政府和制药组织为在该地区传播有关该疾病的认识而采取的举措的增加。
由于亚太地区急性淋巴细胞/淋巴细胞白血病 (ALL) 患病率上升，亚太地区是全球肝脾肿大市场预计增长的地区。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球肝脾肿大市场份额分析
全球肝脾肿大市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球肝脾肿大市场的关注有关。
全球肝脾肿大市场的一些主要参与者包括：
- 安进公司 (美国)
- 百时美施贵宝公司 (美国)
- Erytech Pharma（法国）
- 诺华公司（瑞士）
- 辉瑞公司（美国）
- 罕见疾病治疗公司（美国）
- 赛诺菲（法国）
- Spectrum Pharmaceuticals, Inc.（美国）
- 武田药品工业株式会社 (日本)
- Genmab A/S（丹麦）
- 百特（美国）
- 吉利德科学公司（美国）
- CELGENE 公司（美国）
- 卫材株式会社（日本）
- SymBio Pharmaceuticals Limited（日本）
- Kiadis Pharma（荷兰）
- OBI Pharma（台湾）
- 安斯泰来制药有限公司 (日本)
- Medexus Pharma, Inc.（加拿大）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
